← FDA DRUG APPROVALS

FDA ANDA · ANDA091355

IBUPROFEN

Sponsor: STRIDES PHARMA

APPLICATION
ANDA091355
TYPE
ANDA
ORIGINAL APPROVAL
2011-04-04
LATEST ACTION
2013-04-23
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Over-the-counter

Products

IBUPROFENOver-the-counter
IBUPROFEN 200MG · TABLET · ORAL

Approval history

2013-04-23Labeling · Supplement 1AP
2011-04-04OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →